Saturday, June 10, 2023
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Havana, Jul 6 (Prensa Latina) Studies related to the use of neuroprotective drug NeuralCIM (NeuroEPO) continue in Cuba´s capital by staring off consultations for the classification of patients who will be part of the phase III clinical trial.